![](/themes/custom/ico_theme/assets/dist/images/research_vierge.png)
Lieu / Site
EORTC1407TIGER
Description de l’essai
A randomised phase III trial comparing conventional-Dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high dose chemotherapy using mobilizing paclitaxel followed by High-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumours
Trial sponsor
EORTC
Médecin ICO - Saint-Herblain
EMMANUELLE BOMPAS
Médecin ICO - Angers
REMY DELVA
Type d'intervention évaluée
Chimiothérapie
Date de début de l'essai
08/07/2019
Lien de l'étude : clinicaltrials.gov